Pompano Beach, April 25, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer ofhair care, facial care and other personal care products, announcedtoday its Annual Report for 2012. Total net revenues increased$1,551,562, or 16%, from $9,672,861 for the year ended December 31,2011 to $11,224,424 for the year ended December 31, 2012. Suchexpansion also resulted in an increase in operating expenses. Whilethe company's net loss increased to a $3,623,110 net loss for theyear ended December 31, 2012, the company anticipates recognizingrevenues of approximately $2,000,000 of product orders duringDecember 2012 that it was unable to fulfill prior to December 31,2012. These product orders were subsequently shipped during thethree months ended March 31, 2013. The Company's chief executive officer, Daniel Khesin, stated,"2012 was a tremendous year for DS Healthcare. We launched newproducts, expanded into new markets, while increasing our presencein existing ones, commenced quotation on NASDAQ and completed ourfirst acquisition. Our continued growth and expansion, whileresulting in an increased net loss for the year, marked anotherrecord year of revenues. While our operational expenses increased,we believe such expenses have expedited our continued growth andexpansion and we look forward to continued growth in 2013." On April 18, 2013, the Company received a notice from NASDAQindicating that the Company was not in compliance with one ofNASDAQ's continued listing standards due to the delinquent filingof its annual report on Form 10-K for the year ended December 31,2012 as set forth in NASDAQ Listing Rule 5250(c)(i). Upon filing ofits annual report on April 24, 2013, the Company regainedcompliance with NASDAQ continued listing standards. About DS Healthcare Group DS Healthcare Group, Inc. is a leading developer of hair care,facial care and other personal care products. It markets throughonline and specialty retailers, distributors, cosmetics wholesalersand salons. Its brands include DS Laboratories( www.DSLaboratories.com), Sigma Skin ( www.SigmaSkin.com), PolarisResearch Laboratories ( www.PolarisReserachLabs.com) and Pure Guild( www.ThePureGuild.com). Forward-Looking Statements
Certain statements in this document and elsewhere by DSHealthcare Group are "forward-looking statements" within themeaning of the Private Securities Litigation Reform Act of 1995.Such information includes, without limitation, the businessoutlook, assessment of market conditions, anticipated financial andoperating results, strategies, future plans, contingencies andcontemplated transactions of the Company. Such forward-lookingstatements are not guarantees of future performance and are subjectto known and unknown risks, uncertainties and other factors whichmay cause or contribute to actual results of company operations, orthe performance or achievements of the company or industry results,to differ materially from those expressed, or implied by theforward-looking statements. DS Healthcare Group undertakes noobligation to publicly update any forward-looking statements,whether as a result of new information, future events or otherwise.Actual results, performance or achievements could differ materiallyfrom those anticipated in such forward-looking statements as aresult of certain factors, including those set forth in DSHealthcare Group's filings with the Securities and ExchangeCommission.
CONTACT: Contact: Laurel Moody Corporate Profile 646 810 0608